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Abstract
Current solutions to diagnose bacterial infections though reliable are often time-consuming, laborious and need a specific 
laboratory setting. There is an unmet need for bedside accurate diagnosis of infectious diseases with a short turnaround time. 
Moreover, low-cost diagnostics will greatly benefit regions with poor resources. Immunoassays and molecular techniques 
have been used to develop highly sensitive diagnosis solutions but retaining many of the abovementioned limitations. The 
detection of bacteria in a biological sample can be enhanced by a previous step of capture and enrichment. This will ease 
the following process enabling a more sensitive detection and increasing the possibility of a conclusive identification in the 
downstream diagnosis. This review explores the latest developments regarding the initial steps of capture and enrichment 
of bacteria from complex samples with the ultimate goal of designing low cost and reliable diagnostics for bacterial infec-
tions. Some solutions use specific ligands tethered to magnetic constructs for separation under magnetic fields, microfluidic 
platforms and engineered nano-patterned surfaces to trap bacteria. Bulk acoustics, advection and nano-filters comprise some 
of the most innovative solutions for bacteria enrichment.
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Introduction
Infectious diseases including lower respiratory infections, 
tuberculosis and diarrheal diseases are among the top ten 
causes of mortality globally, ahead of dementia, cancer and 
diabetes mellitus [1]. For instance, every year, nearly 1.7 
billion cases of childhood diarrheal disease are registered, 
being mainly transmitted by pathogens such as Escherichia 
coli present in contaminated food and water [2]. The scale 
of diseases prevalence, multiplicity of bacterial species and 
strains involved and disease incidence, in addition to the 
emergence of opportunistic pathogens, make clinical diag-
nostics a challenging task, especially in places with lack of 
resources.
Culture-based assays continue to be the gold standard 
for bacteria identification [3]. However, this methodology 
is time-consuming taking several days in some cases [4]. 
Moreover, highly skilled labor and a specific laboratory set-
ting is required, which can limit their use in some places 
where proper facilities are not available. In the last decades, 
several immunological and molecular methods have been 
developed for pathogen diagnostics with a high level of sen-
sitivity and accuracy. The most popular methods include 
immuno-based biosensors, enzyme-linked immunosorbent 
assay (ELISA) and molecular methods such as polymerase 
chain reaction (PCR), mass spectrometry (MS) and more 
recently, loop-mediated isothermal amplification (LAMP) 
and next generation sequencing (NGS) [4]. Though highly 
sensitive, these methods involve complex, time-consuming 
sample preparation steps, sophisticated laboratory equip-
ment and highly skilled labor.
Despite of the current availability of a multitude of bacte-
ria identification methods, there is still an enormous unmet 
need for fast, easy to use, cost-effective and highly sensitive 
point-of-care (POC) diagnostics. Capture and enrichment 
techniques can be achieved with compact devices, which 
can potentially provide bedside diagnostics. In addition, 
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sometimes the number of pathogens present in biological 
samples are lower than the detection limits of the available 
methods, thus requiring additional pre-enrichment steps 
which add costs to the diagnostics and increase the turna-
round time. Moreover, samples usually associated with low 
bacterial numbers (e.g., CNS fluid) or in mixed populations 
(e.g., stool), can benefit from a diagnostic approach using 
capture and enrichment of samples prior to downstream pro-
cessing. This review explores the most recent developments 
regarding materials, methods and approaches for capturing 
and/or enriching bacteria from biological complex samples 
towards the design of more straight-forward and cost-effec-
tive clinical diagnostic methods to be used in a POC setting 
(Fig. 1).
New materials and methods to capture and enrich 
bacteria from biological samples
Many efforts have been conducted in the recent years 
towards the development of innovative diagnostics against 
several diseases. These involve the search and engineering of 
specific ligands (antibodies, peptides, aptamers), the design 
and fabrication of new materials exhibiting a panoply of rel-
evant physicochemical features (hydrophilicity/hydrophobic-
ity; conductivity; wettability; rigidity; roughness; flexibility; 
biocompatibility; among others), and the combination of dif-
ferent separation (affinity, molecular weight, acoustic) and 
detection (fluorescence, electrochemistry, absorbance) prin-
ciples to enable the efficient capture of specific pathogens 
from complex samples (blood, urine, stool), their enrichment 
and qualitative and/or quantitative detection.
Magnetic beads
Aptamers can be raised against virtually any target through 
SELEX (Systematic evolution of ligands by exponential 
enrichment) [7], thus opening a number of opportunities 
for the development of innovative and cheap diagnostics. A 
POC, aptamer-mediated biosensor was developed to aid in 
malaria diagnosis [5]. Aptamers are oligonucleotides frag-
ments (DNA or RNA) that bind to their targets with high 
affinity and specificity [6]. An aptamer that specifically rec-
ognizes the Plasmodium falciparum lactate dehydrogenase 
(PfLDH) enzyme was designed and coated onto magnetic 
microbeads towards its magnet-guided capture and col-
orimetric detection on a microfluidic platform. Moreover, 
the biosensor developed a signal within 20 min of adding a 
development reagent and the cost of the microfluidic plat-
forms are not expensive costing about 3 USD per cassette.
In a recent work [8], the long tail fibers (S16 LTF) of 
a bacteriophage that specifically binds Salmonella were 
immobilized onto paramagnetic beads that were further 
used to capture Salmonella cells from different samples. 
Bacteriophages are viruses that can only live and replicate 
within bacteria. They infect hosts by binding to surface 
receptors by their long tail fibers with unmatched specific-
ity. Due to the inherent specificity of these bacteriophage tail 
fiber to bind distinct bacterial species they are suitable affin-
ity molecules. Concentrations of captured bacteria between 
 102 and  107 CFU/mL were detected by a change in color of 
the enzymatic label used. Alternatively, specific peptides 
against different target pathogens can be selected by Phage 
Display [7] and further used to modify magnetic beads lead-
ing to new diagnostics.
Most reports provide proof-of-concept studies using 
synthetic samples to validate their capture and enrichment 
models. However, the results do not always translate to a sce-
nario where real samples are used as discussed by Bicart-See 
and collaborators [9]. These authors evaluated the success 
of bacteria capture from clinical samples. Staphylococcus 
aureus was isolated from articular fluid and synovial tis-
sue using magnetic beads coated with an engineered chi-
meric human opsonin protein, Fc-mannose-binding lectin 
(FcMBL). The direct capture from clinical samples was 
found to be very inefficient (lower than 5%). Masking of 
FcMBL binding sites by immunoglobulins and immune 
cells, as well as the high viscosity of complex biological 
samples were found to be the main reason responsible for the 
low capture efficiency. However, through a pre-treatment of 
the clinical tissue samples with hypotonic washes, hyaluro-
nidase and proteases, FcMBL capture efficiency increased 
to 76%.
Magnetic nanoparticles
Wang and colleagues [10] developed a technique using iron 
oxide magnetic nanoparticles (MNP) functionalized with 
aptamers to specifically bind S. aureus and E. coli. Addi-
tional functionalization groups involved a photosensitizer 
chlorin e6 for detection by fluorescence microscopy and 
polyethylene glycol (PEG) to improve the stability and bio-
compatibility of the MNPs. The ultimate goal was to provide 
a quick turnaround time for diagnosis of sepsis, which can 
be fatal if not reversed within few hours. The developed 
solution enabled capturing and detecting trace amounts of 
bacteria (10 CFU) within 1.5 h from mouse blood.
Similarly, MNPs containing an iron oxide magnetite core 
were functionalized with an amino-glycan coating [11]. 
These MNPs were fixed to plastic strips and used to rapidly 
capture bacteria directly from complex matrices by dip-
ping the strips into the sample. The MNP fixed to the strips 
have hydroxyl, amino and hydrophobic regions that interact 
with bacterial membranes and their surface epitopes form-
ing non-covalent electrostatic bonds similar to those found 
in antibody bonding. Overall, the MNP-strip capture aided 
with a cyclic voltammetry detection system, detected cells 
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in less than 30 min, without requiring an initial separation of 
targeted cells from the matrix. In addition, the use of plastic 
strips for bacteria capture significantly reduces costs.
In a recent development [12], a microfluidic channel 
was designed with a slanted ridge array that induces advec-
tive spiral flows when a sample fluid flows through the 
Fig. 1  Overview of the methods to capture bacteria from biological 
samples. a Magnetic beads functionalized with ligands that bind bac-
teria and can be enriched by magnetic separation. b Functionalized 
magnetic nanoparticles are used to bind bacteria and are enriched by 
magnetic separation. c Various types of nano-topographies such as 
prickly or nano-patterned surfaces can be engineered to trap bacte-
ria. d. Surfaces functionalized with chemical cross linkers and ligands 
that can directly capture bacteria. e Physical barriers such as nano-
filters can be used to trap bacteria from a sample flowing through it. 
Combinations of all these methods have also been explored to capture 
bacteria from complex samples
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microfluidic channel causing enhanced separation of mag-
netized particles present in the sample. Cells bound with 
magnetic particles in the presence of the advective flow are 
repeatedly transferred close to a ferromagnetic nickel struc-
ture, where they can be captured easily, since the magnetic 
field is the strongest in the vicinity of the magnet. This sys-
tem was validated using super-paramagnetic nanoparticles 
coated with mannose-binding lectin and bound to E. coli 
spiked onto undiluted whole blood from rats. 91.6% of E. 
coli bound to the MNPs were successfully separated as com-
pared to only 23.9% of E. coli collected in a conventional 
microfluidic device.
Nano‑patterned 3D surfaces
Nano-patterned 3D surfaces have higher binding capaci-
ties compared with flat substrates [13]. These surfaces offer 
more reactive sites to bind with bacterial targets. Several 
nanostructures have been evaluated regarding their ability to 
capture the target bacteria, including nanowires, nanofractals 
and nanofibers [14].
Zinc oxide nanorod arrays were fabricated by an electro-
chemical method to form a 3D nano–bio surface functional-
ized with lectin Concanavalin A (ConA) to capture E. coli 
[15]. Lectins are effective ligands due to their specificity of 
binding polysaccharide components on bacterial cells sur-
faces. The results showed a reasonable detection limit of 
0.9 × 102 CFU/mL in saline-spiked E. coli.
Li and colleagues [14] further demonstrated the synergis-
tic effect of 3D topography coupled with surface chemical 
modification to increase bacteria attachment and binding 
efficiency. Densely packed nanowire arrays were fabricated 
on silicon wafers such that the space between nanowire 
structures was smaller than the diameter of a bacterium 
to improve the binding. ConA molecules were introduced 
onto the nanowires through sequential chemical covalent 
coupling to confer selective bacteria recognition capabili-
ties. ConA has high affinity for bacterial lipopolysaccharide 
components and the capture sensitivity of test assays was 
10 CFU/mL. The functionalized nanowires were found to 
capture up to ten times more S. aureus than the silicon‐ConA 
substrate without nanowires and within a short incubation 
time of 30 min, thus suggesting the critical role of the 3D 
topography in an enhanced capture of bacteria.
A dialyzer made with 3D carbon foam and grafted with 
nanowires was used to capture bacteria from human blood 
samples [16]. Pointed polycrystalline nanowires bent readily 
to form 3D ‘nanoclaws’ to trap bacteria due to a decreasing 
Young’s moduli from the bottom to the tip resulting from 
sample flow. Bacteria-capture efficiency was improved from 
10% on plain carbon foam and 40% on unbendable nanow-
ires on carbon foam to 97% on bendable polycrystalline 
nanowires on carbon foam when placed in a simulated 
bloodstream flowing at 10 cm/s.
Sensors were fabricated by in situ deposition of prickly 
Zn–CuO nanoparticles and graphene oxide nanosheets on 
an Ni porous electrode [17]. Due to burr-like nanostructures 
on the surface, the sensor exhibited excellent bacteria-cap-
ture efficiency (70–80% in 20 min) at low concentrations 
of 50 CFU/mL, and high detection sensitivity with lower 
limit of 10 CFU/mL. An excellent detection of bacteria at 
concentrations ranging from 10 to  105 CFU/mL within a 
short time interval of 30 min was observed using an E. coli 
spiked rat blood sample.
Methods involving specific chemicals and ligands
Wang et al. [18] developed a multifunctional chip compris-
ing a silicon wafer functionalized with 4-mercaptophe-
nylboronic (4-MPBA). The 4-MPBA molecule possesses a 
boronic acid group that is known to reversibly bind pep-
tidoglycan from bacterial cell walls enabling the specific 
capture of several bacteria. In addition, 4-MPBA has also 
been bound to silver nanoparticles for cell lysis and to a ben-
zene ring that can amplify signals of the captured bacteria 
for their detection and identification. In terms of efficiency, 
1 × 102 cells/mL of E. coli or S. aureus were accurately iden-
tified in human blood, thus making it sensitive enough to 
detect bacteria in the blood of sepsis patients. Yang et al. 
[19] reported a similar solution using 4-MPBA on a semi-
conductor substrate. The platform was able to capture E. 
coli with high specificity and sensitivity with a detection 
limit as low as 46 CFU/mL of E. coli from a test suspension. 
Moreover, this class of SERS chip can be easily and cheaply 
fabricated increasing the likelihood of its use for practical 
applications.
A herringbone-type microfluidic platform contained a 
Magainin 1 peptide immobilized on its surface to enrich 
a test bacteria from urine samples [20]. Magainin 1 semi-
selectively binds to Gram-negative bacteria species. The 
platform was coupled with a recombinase polymerase 
amplification (RPA) sensor for simultaneous pathogenic 
DNA amplification and detection in a real time and highly 
sensitive manner. The detection limit was found to be 20 
times more sensitive in 10 mL urine with Salmonella and 
ten times more sensitive in 10 mL urine with Brucella than 
that of real-time PCR without the enrichment step. The 
combination of ligand-based enrichment and an RPA sensor 
exhibited a detection sensitivity of 5 CFU/mL urine for Sal-
monella and 10 CFU/ml urine for Brucella within 60 min.
Methods involving sound wave acoustophoresis
A number of microfluidic separation methods have been 
used to separate bacteria from the bulk sample such as 
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centrifugal microfluidics and dielectrophoresis [21]. Acou-
stophoresis has recently been demonstrated as an effective 
technique to separate components from a bulk fluid in the 
presence of sound waves into separate streams [21]. This 
method has proven to be useful in sepsis diagnosis due to 
the quick turnaround time and possibly for blood disinfec-
tion given that it can be scaled-up to handle larger volumes.
In a recent example [22], bulk acoustophoresis was 
used to separate bacteria from the blood cells from whole 
blood samples. The small size of bacteria prevents them 
from being affected by an acoustic field, and therefore, they 
remain in the blood plasma flow that is directed to a sepa-
rate outlet. Upon optimization of the sample volume, it was 
found that 1 ml of undiluted whole blood can be processed 
within 12.5 min, with a bacteria recovery of 90% and almost 
100% blood cell removal.
In addition, bulk acoustophoresis was used to identify 
bacteria using a bacteriophage-based luminescence assay in 
a microfluidic chip [23]. To demonstrate the effectiveness of 
the acoustophoretic system, three clinically relevant species 
of bacteria were tested, namely, Pseudomonas aeruginosa, 
S. aureus and E. coli. Bacteria recovery from blood samples 
was between 45% and 60% across species while removing 
more than 85% of blood cells.
Methods involving physical barriers
Novel microfluidic immune-affinity columns consisting of 
packed microbeads functionalized with antibodies were 
used to provide large surface areas for effective capture of 
uropathogenic E. coli [24]. Due to the capillary action of the 
channels in the columns, the sample, antibody and fluores-
cent label were dispensed autonomously and the assay time 
was very fast (7 min). The detection limit of E. coli in syn-
thetic urine was 1.2 × 102 CFU/mL, which is well below the 
cutoff of  105 CFU/mL of a single organism which is often 
used as a cutoff point in the diagnosis of uncomplicated uri-
nary tract infections.
Another device was fabricated based on the self-assembly 
of polystyrene microparticles at a pillar array region within 
a microfluidic chip to form a nanoscale filter for bacteria 
capture from samples flowing on gold nano/micro islands 
[25]. The nanosurface microfluidic device showed an aver-
age capture efficiency of 93% E. coli from samples.
Methods involving mixed separation principles
PEG hydrogel bead-like scaffolds were functionalized with 
aptamers to specifically target S. aureus and E. coli. PEG 
is used to decrease non-specific adsorption of other tar-
gets. This PEG scaffold was tagged with MNPs to simplify 
the processing of the bioassays. In addition, the scaffolds 
were nano-patterned to increase the surface area for probe 
immobilization and greatly enhance binding efficiency of 
target bacteria. Multiple bacterial species were captured 
from human blood spiked with S. aureus and E. coli with 
concentrations as low as 100 CFU/mL within 2.5 h [26].
A reusable supramolecular platform was developed for 
the specific capture and release of bacteria and proteins 
[27]. The platform exploited the carbohydrate–protein affin-
ity recognition to capture specific proteins and bacteria. It 
used multi-layering polyelectrolyte films, followed by the 
incorporation of β-cyclodextrin (β-CD) derivatives modified 
with mannose as host molecules which were demonstrated to 
bind type I fimbriae E. coli and lectin proteins. The special 
feature of this platform is that captured bacteria could be 
released from the surface by incubation with sodium dodecyl 
sulfate and the platform can then be reused. This versatile 
and reusable system is very promising and could comprise 
the basis for the development of new, cheap and reusable 
diagnostic devices.
Conclusion and outlook
Classical methods used for bacterial infection diagnosis are 
reliable, however, in an era where faster, more convenient 
and flexible solutions are constantly demanded, the realm of 
diagnostics is no exception. There is a clear need for faster 
results using simple and cheap miniaturized platforms. 
Innovators in the diagnostics field have been inspired by 
the semiconductor industry to develop microfluidic devices 
and ‘chips’ to capture, detect and quantify diverse microor-
ganisms. The great advantage of these microfluidic devices 
and compact sensors is that they are cheaply manufactured, 
costing as little as a few USD in many cases reducing the 
overall costs. Other cost-saving examples include the use 
of materials such as polystyrene and paper to manufacture 
some of the innovative devices herein described, or the use 
of aptamers as specific ligands, which are cheap and easy 
to synthesize.
In addition, relevant contributions from the nanotechnol-
ogy and synthetic biology fields led to the development of 
targeted micro/nanoparticles for capture and detection pur-
poses. Immunoassays, chemical ligand-mediated capture 
and functionalized magnetic microbeads or nanoparticles 
are among the successful solutions developed to capture bac-
terial cells in microfluidic devices. As a result, turnaround 
times have been reduced from many hours to minutes in 
some cases and miniaturization promises fast, sensitive and 
easy to use POC diagnostic devices. However, before these 
new solutions translate into an important improvement in 
the infection diagnostics field, they must be tested beyond 
the developmental stage. One relevant challenge includes 
validating these new solutions using patient samples (blood, 
urine, stool) that are more complex and heterogeneous than 
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the synthetic samples commonly used at the developmental 
stage. Therefore, it is always important to bear in mind that 
even if a diagnostic method performs very well with syn-
thetic samples, it might need further adjustments and optimi-
zations before it can be used in a real context with biological 
samples. In addition, while in theory, these new solutions 
appear to be cost-effective, some use expensive ligands (e.g., 
antibodies) and, for instance, the design of complex and 
sophisticated microfluidic platforms can also significantly 
increase costs. Other solutions being proposed bypass the 
analyte–ligand binding making use of nano-patterned sur-
faces or micro/nano-obstacles and filters to capture bacteria. 
However, these solutions may lack specificity. An alternative 
approach could be to use inexpensive ligand biomolecules 
(e.g., aptamers) immobilized onto available and common 
polymeric substrates (e.g., silicon), thereby taking advantage 
of the specificity and sensitivity of the ligand coupled to a 
cheap platform. The development of these innovative solu-
tions will undoubtedly lead to a new generation of tools to 
capture and detect bacteria, thus making POC diagnosis of 
an infection within hours or even minutes and overcoming 
the limitations of the conventional methods, a reality.
Funding This research is affiliated to the VibrANT project that 
received funding from the EU Horizon 2020 Research and Innovation 
Programme under the Marie Sklowdowska-Curie Grant, agreement no 
765042. In addition, MGS, TC and LRR acknowledge the financial sup-
port from Fundação para a Ciência e Tecnologia (FCT) under the scope 
of the strategic funding of UID/BIO/04469/2020 unit and COMPETE 
2020 (POCI-01-0145-FEDER-006684), through national funds and 
where applicable co-financed by the FEDER, within the PT2020 Part-
nership Agreement. The same authors also acknowledge BioTecNorte 
operation (NORTE-01-0145-FEDER-000004) funded by the European 
Regional Development Fund under the scope of Norte2020-Programa 
Operacional Regional do Norte.
Compliance with ethical standards 
Conflict of interest The authors declare no conflict of interest.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. WHO (2015) The top 10 causes of death. http://who.int/media 
centr e/facts heets /fs310 /en/. Accessed 1 July 2019
 2. Word Health Organization (2013) Diarrhoeal disease 2013. https 
://www.who.int/news-room/fact-sheet s/detai l/diarr hoeal -disea se. 
Accessed 1 July 2019
 3. Fournier PE, Dubourg G, Raoult D (2014) Clinical detection 
and characterization of bacterial pathogens in the genomics era. 
Genome Med 6:1–15
 4. Zhang D, Bi H, Liu B, Qiao L (2018) Detection of pathogenic 
microorganisms by microfluidics based analytical methods. Anal 
Chem 90:5512–5520
 5. Fraser LA, Kinghorn AB, Dirkzwager RM, Liang S, Cheung YW, 
Lim B, Shiu SCC, Tang MSL, Andrew D, Manitta J, Richards 
JS, Tanner JA (2018) A portable microfluidic Aptamer-Tethered 
Enzyme Capture (APTEC) biosensor for malaria diagnosis. Bio-
sens Bioelectron 100:591–596
 6. Templier V, Roux A, Roupioz Y, Livache T (2016) Ligands for 
label-free detection of whole bacteria on biosensors: a review. 
TRAC Trends Anal Chem 79:71–79
 7. Rodrigues JL, Ferreira D, Rodrigues LR (2017) Synthetic biology 
strategies towards the development of new bioinspired technolo-
gies for medical applications. In: Rodrigues LR, Mota M (eds) 
Bioinspired materials for medical applications. WoodHead Pub-
lishing, Elsevier, Amsterdam
 8. Dunne M, Loessner MJ (2019) Modified bacteriophage tail fiber 
proteins for labeling, immobilization, capture, and detection of 
bacteria. Methods Mol Biol 1918:67–86
 9. Bicart-See A, Rottman M, Cartwright M, Seiler B, Gamini N, 
Rodas M, Penary M, Giordano G, Oswald E, Super M, Ingber 
DE (2016) Rapid isolation of Staphylococcus aureus pathogens 
from infected clinical samples using magnetic beads coated with 
Fc-mannose binding lectin. PLoS One 11:1–12
 10. Wang J, Wu H, Yang Y, Yan R, Zhao Y, Wang Y, Chen A, Shao 
S, Jiang P, Li YQ (2018) Bacterial species-identifiable magnetic 
nanosystems for early sepsis diagnosis and extracorporeal photo-
dynamic blood disinfection. Nanoscale 10:132–141
 11. Matta LL, Harrison J, Deol GS, Alocilja EC (2018) Carbohydrate-
functionalized nanobiosensor for rapid extraction of pathogenic 
bacteria directly from complex liquids with quick detection using 
cyclic voltammetry. IEEE Trans Nanotechnol 17:1006–1013
 12. Jung SH, Hahn YK, Oh S, Kwon S, Um E, Choi S, Kang JH 
(2018) Advection flows-enhanced magnetic separation for high-
throughput bacteria separation from undiluted whole blood. Small 
14:1–7
 13. Wang S, Zhang P, Liu H, Jiang L, Xu T, Meng J, Liu X, Yang G, 
Chen L (2013) Programmable fractal nanostructured interfaces for 
specific recognition and electrochemical release of cancer cells. 
Adv Mater 25:3566–3570
 14. Li YQ, Zhu B, Li Y, Leow WR, Goh R, Ma B, Fong E, Tang M, 
Chen X (2014) A synergistic capture strategy for enhanced detec-
tion and elimination of bacteria. Angew Chemie Int 53:5837–5841
 15. Zheng L, Wan Y, Qi P, Sun Y, Zhang D, Yu L (2017) Lectin func-
tionalized ZnO nanoarrays as a 3D nano-biointerface for bacterial 
detection. Talanta 167:600–660
 16. Liu L, Chen S, Xue Z, Zhang Z, Qiao X, Nie Z, Han D, Wang J, 
Wang T (2018) Bacterial capture efficiency in fluid bloodstream 
improved by bendable nanowires. Nat Commun 9:1–9
 17. Wu R, Ma Y, Pan J, Lee SH, Liu J, Zhu H, Gu R, Shea KJ, Pan G 
(2018) Efficient capture, rapid killing and ultrasensitive detection 
of bacteria by a nano-decorated multi-functional electrode sensor. 
Biosens Bioelectron 101:52–59
 18. Wang H, Zhou Y, Jiang X, Sun B, Zhu Y, Wang H, Su Y, He 
Y (2015) Simultaneous capture, detection, and inactivation of 
341Medical Microbiology and Immunology (2020) 209:335–341 
1 3
bacteria as enabled by a surface-enhanced Raman scattering mul-
tifunctional chip. Angew Chemie Int 54:5132–5136
 19. Yang Z, Wang Y, Zhang D (2018) An integrated multifunctional 
photoelectrochemical platform for simultaneous capture, detec-
tion, and inactivation of pathogenic bacteria. Sens Actuator B 
Chem 274:228–234
 20. Dao TNT, Lee EY, Koo B, Jin CE, Lee TY, Shin Y (2018) A 
microfluidic enrichment platform with a recombinase polymer-
ase amplification sensor for pathogen diagnosis. Anal Biochem 
544:87–92
 21. Pitt WG, Alizadeh M, Husseini GA, McClellan DS, Buchanan 
CM, Bledsoe CG, Robison RA, Blanco R, Roeder BL, Melville 
M, Hunter AK (2016) Rapid separation of bacteria from blood-
review and outlook. Biotechnol Prog 32:823–839
 22. Ohlsson P, Petersson K, Augustsson P, Laurell T (2018) Acoustic 
impedance matched buffers enable separation of bacteria from 
blood cells at high cell concentrations. Sci Rep 8:1–11
 23. Dow P, Kotz K, Gruszka S, Holder J, Fiering J (2018) Acoustic 
separation in plastic microfluidics for rapid detection of bacteria 
in blood using engineered bacteriophage. Lab Chip 18:923–932
 24. Olanrewaju AO, Ng A, Decorwin-Martin P, Robillard A, Juncker 
D (2017) Microfluidic capillaric circuit for rapid and facile bac-
teria detection. Anal Chem 89:6846–6853
 25. Abdelfatah T, Jalali M, Mahshid S (2018) A nanosurface micro-
fluidic device for capture and detection of bacteria. IEEE Life Sci 
Conf LSC 2018:167–170
 26. Xu Y, Wang H, Luan C, Liu Y, Chen B, Zhao Y (2018) Aptamer-
based hydrogel barcodes for the capture and detection of multiple 
types of pathogenic bacteria. Biosens Bioelectron 100:404–410
 27. Qu Y, Wei T, Zhan W, Hu C, Cao L, Yu Q, Chen H (2017) A reus-
able supramolecular platform for the specific capture and release 
of proteins and bacteria. J Mater Chem B 5:444–453
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
